Items where Author is "Hillert, J."

Article

Kappos, L. and Bates, D. and Edan, G. and Eraksoy, M. and Garcia-Merino, A. and Grigoriadis, N. and Hartung, H. P. and Havrdova, E. and Hillert, J. and Hohlfeld, R. and Kremenchutzky, M. and Lyon-Caen, O. and Miller, A. and Pozzilli, C. and Ravnborg, M. and Saida, T. and Sindic, C. and Vass, K. and Clifford, D. B. and Hauser, S. and Major, E. O. and O'Connor, P. W. and Weiner, H. L. and Clanet, M. and Gold, R. and Hirsch, H. H. and Radu, E. W. and Sorensen, P. S. and King, J.. (2011) Natalizumab treatment for multiple sclerosis : updated recommendations for patient selection and monitoring. The Lancet neurology, Vol. 10, H. 8. pp. 745-758.

Farrell, R. and Bendtzen, K. and Bertolotto, A. and Clark, B. and Comabella, M. and Deisenhammer, F. and Fogdell-Hahn, A. and Giovannoni, G. and Hartung, H. P. and Hemmer, B. and Hillert, J. and Kappos, L. and Killestein, J. and Lindberg, R. and Montalban, X. and Polman, C. and Sorensen, P. S. and European, Nabinms Consortium. (2008) Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of international medical research, Vol. 36, H. 1 , S. 204-208 ; author reply 208-210.